Geography

Edinburgh BioQuarter is a 65 hectare (160 acre) healthcare and medical research campus in the Little France neighbourhood in south-east Edinburgh. 8,000 people currently work at Edinburgh BioQuarter, including clinicians, academics, and commercial researchers. Research carried out at Edinburgh BioQuarter focuses on major diseases. There is a strong focus on translational "bench to bedside" medicine, converting novel research into new treatments.

Companies with a presence at Edinburgh BioQuarter include pharmaceuticals giant GSK; medical devices companies CALCiViS and SIRAKOSS; bio-manufacturer Nandi Proteins; contract research organisation Aquila BioMedical, contract manufacturing organisation Roslin Cells; and bioinformatics specialist Fios Genomics.

Healthcare and medical research facilities

Major investment has been carried out to date, with Edinburgh BioQuarter home to the following purpose-built healthcare and medical research facilities:

• The Royal Infirmary of Edinburgh, a 900-bed acute teaching hospital.
• The Royal Hospital for Children and Young People, a 242-bed paediatric hospital. 
• The Chancellor's Building, home of the University of Edinburgh's world-renowned Edinburgh Medical School.
• The Queen's Medical Research Institute, a University of Edinburgh clinical research facility that houses the Centre for Cardiovascular Science; Centre for Inflammation Research; and MRC Centre for Reproductive Health.
• The MRC Centre for Regenerative Medicine and Centre for Tissue Repair, University of Edinburgh research facilities specialising in stem cells and tissue repair (collectively making up the Institute for Regeneration and Repair).
• The Anne Rowling Regenerative Neurology Clinic, a University of Edinburgh clinical research facility specialising in neurodegenerative diseases.
• NINE, a purpose-built innovation centre providing 7,900 square metres (85,000 square feet) of CAT 2 laboratory space and office space, including flexible space for early-stage companies.
• The BioCubes, two buildings offering a total of 1,700 square metres (18,000 square feet) of CAT 2 laboratory space and office space.

Expansion of Edinburgh BioQuarter

A £750 million expansion of Edinburgh BioQuarter that would evolve the area into a vibrant mixed-use neighbourhood is planned. The expansion would deliver additional healthcare and research space, along with housing, a hotel, and retail and leisure space, creating around 9,000 new jobs. The expansion is being take forward as a partnership between the City of Edinburgh Council, NHS Lothian, Scottish Enterprise, and the University of Edinburgh. A development partner is being procured to take forward the development.